EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial

Darrick K Li, David Cheng, Anna Parks, Meghan L Rieu-Werden, Galina Polekhina, Suzanne E Mahady, M Maria Glymour, Andrew T Chan, Sachin J Shah

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.02.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Darrick K Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Aspirin, Hemorrhage, Platelet Aggregation Inhibitors, Fibrinolytic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinically significant extracranial bleeding, defined as bleeding at any site other than the brain or spinal cord requiring either a hospital admission >24 hours, red blood cell transfusion, surgery for hemostasis, or resulting in death, is a common side effect of antithrombotic agents. Compared to intracranial bleeding, the impact of clinically significant extracranial bleeding on long-term outcomes, including functional independence, has been poorly studied. OBJECTIVES: To determine if clinically significant extracranial bleeding impacts the development of functional disability in healthy older adults. METHODS: We performed a secondary analysis of the Aspirin in Reducing Events in the Elderly trial. The primary outcome of this study was incident dependence in the Katz Activities of Daily Living (ADLs), defined as being unable to perform or requiring assistance with any ADLs or being admitted to a long-term care facility. RESULTS: A total of 18 982 participants were included in the analysis, of which 547 (2.9%) developed clinically significant extracranial bleeding during study follow-up. In adjusted analyses, clinically significant extracranial bleeding was significantly associated with the development of incident ADL dependence (hazard ratio [HR], 2.46; 95% CI, 1.97-3.07). This finding was similar for gastrointestinal (HR, 2.29; 95% CI, 1.72-2.08) and nongastrointestinal extracranial bleeds (HR, 2.68; 95% CI, 1.96-3.69). The association with increased risk of incident ADL dependence remained significant in secondary analysis of groups randomized to either aspirin (HR, 2.15; 95% CI, 1.57-2.94) or placebo (HR, 2.84; 95% CI, 2.09-3.86). CONCLUSION: Clinically significant extracranial bleeding was associated with the development of incident ADL dependence in otherwise healthy older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinHemorrhagePlatelet Aggregation InhibitorsFibrinolytic AgentsHumansAgedMaleFemaleActivities of Daily LivingAged, 80 and overRisk FactorsDisability EvaluationTreatment OutcomeTime FactorsAge Factors

Stichwörter der Autor:innen

disabilityextracranial bleedingfunctional independence

Substanzen

AspirinPlatelet Aggregation InhibitorsFibrinolytic Agents

Autor:innen und Institutionen

  • Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Hematology & Hematologic Malignances, University of Utah, Salt Lake City, Utah, USA.
  • Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • National Institute on Aging

Zitieren

APA

Li, D. K., Cheng, D., Parks, A., Rieu-Werden, M. L., Polekhina, G., Mahady, S. E., Glymour, M. M., Chan, A. T., & Shah, S. J. (2025). Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.02.013

Vancouver

Li DK, Cheng D, Parks A, Rieu-Werden ML, Polekhina G, Mahady SE, et al. Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.02.013

BibTeX
@article{Li2025,
  author = {Li, Darrick K and Cheng, David and Parks, Anna and Rieu-Werden, Meghan L and Polekhina, Galina and Mahady, Suzanne E and Glymour, M Maria and Chan, Andrew T and Shah, Sachin J},
  title = {Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.02.013}
}
Kostenlos starten →